ReviewImmunotherapy2011
Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer.
Rachel N Grisham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewImmunotherapy2011
Rachel N Grisham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.